Amber D. Van Laar

LRRK2 activation in idiopathic Parkinson’s disease

Roberto Di Maio, Eric K. Hoffman, Emily M. Rocha et al. · Science Translational Medicine · 2018 · 603 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Unregulated Cytosolic Dopamine Causes Neurodegeneration Associated with Oxidative Stress in Mice

Linan Chen, Yunmin Ding, Barbara Cagniard et al. · Journal of Neuroscience · 2008 · 240 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Magnetic resonance imaging–guided phase 1 trial of putaminal <i>AADC</i> gene therapy for Parkinson's disease

Chadwick W. Christine, Krystof S. Bankiewicz, Amber D. Van Laar et al. · Annals of Neurology · 2019 · 160 citations · Full text

Medicine, Neurology, Neuroscience +17

Alpha‐synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells

Roya Tehranian, Susana E. Montoya, Amber D. Van Laar et al. · Journal of Neurochemistry · 2006 · 113 citations

Life Sciences, Neurobiology, Neuroscience +17

Erythropoietin protects against 6‐hydroxydopamine‐induced dopaminergic cell death

Armando P. Signore, Zhongfang Weng, Teresa G. Hastings et al. · Journal of Neurochemistry · 2005 · 90 citations

Life Sciences, Neuroscience, Pharmacology +17